PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,960 | -29.0% | 97,124 | -0.9% | 0.15% | -40.9% |
| Q4 2022 | $287,076 | -78.9% | 97,978 | -82.7% | 0.25% | -85.3% |
| Q3 2022 | $1,362,000 | -42.7% | 567,600 | -46.5% | 1.72% | +6.2% |
| Q2 2022 | $2,378,000 | -19.0% | 1,061,411 | -16.8% | 1.62% | +269.4% |
| Q1 2022 | $2,934,000 | -3.6% | 1,275,468 | +4.7% | 0.44% | -1.1% |
| Q4 2021 | $3,045,000 | -4.9% | 1,217,828 | +20.6% | 0.44% | +2.3% |
| Q3 2021 | $3,202,000 | – | 1,010,146 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |